229 related articles for article (PubMed ID: 25774942)
1. Interleukin-21 inhibits HBV replication in vitro.
Li HJ; Kang FB; Li BS; Yang XY; Zhang YG; Sun DX
Antivir Ther; 2015; 20(6):583-90. PubMed ID: 25774942
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo.
Cheng ST; Tang H; Ren JH; Chen X; Huang AL; Chen J
PLoS One; 2017; 12(6):e0179605. PubMed ID: 28614380
[TBL] [Abstract][Full Text] [Related]
4. Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon λ1 (IFN-λ1).
Li Y; Xie J; Xu X; Liu L; Wan Y; Liu Y; Zhu C; Zhu Y
J Biol Chem; 2013 Jul; 288(29):20927-20941. PubMed ID: 23729669
[TBL] [Abstract][Full Text] [Related]
5. Suppression of hepatitis B virus replication in Tupaia hepatocytes by tumor necrosis factor alpha of Tupaia belangeri.
Xu Y; Köck J; Lu Y; Yang D; Lu M; Zhao X
Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):361-8. PubMed ID: 21684599
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
7. Increased interleukin-32, interleukin-1, and interferon-γ levels in serum from hepatitis B patients and in HBV-stimulated peripheral blood mononuclear cells from healthy volunteers.
Tian ZJ; Shen Y; Li XR; Wei YN; Fan H; Ren QK
J Infect Public Health; 2019; 12(1):7-12. PubMed ID: 30006119
[TBL] [Abstract][Full Text] [Related]
8. Effect of IL-18 on peripheral blood mononuclear cells of chronic hepatitis B and hepatitis B virus DNA released by HepG2.2.15 cell lines.
Sun Y; Chen HY; Xin SJ
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):230-4. PubMed ID: 15138116
[TBL] [Abstract][Full Text] [Related]
9. Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
Xia Y; Stadler D; Lucifora J; Reisinger F; Webb D; Hösel M; Michler T; Wisskirchen K; Cheng X; Zhang K; Chou WM; Wettengel JM; Malo A; Bohne F; Hoffmann D; Eyer F; Thimme R; Falk CS; Thasler WE; Heikenwalder M; Protzer U
Gastroenterology; 2016 Jan; 150(1):194-205. PubMed ID: 26416327
[TBL] [Abstract][Full Text] [Related]
10. The effect of interleukin-6 on hepatitis B virus replication in peripheral blood mononuclear cells in vitro.
Sidorkiewicz M; Jóźwiak B; Sulowska Z; Greger J; Lewandowska U
Acta Virol; 2004; 48(3):153-8. PubMed ID: 15595208
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the hepatitis B virus replication in vitro by an oligodeoxynucleotide containing cytidine-guanosine motifs.
Li N; Fan XG; Chen ZH; Zhu C; Liu HB; Huang Y
Immunol Lett; 2006 Jan; 102(1):60-6. PubMed ID: 16105691
[TBL] [Abstract][Full Text] [Related]
12. DNA-dependent activator of interferon-regulatory factors inhibits hepatitis B virus replication.
Chen QY; Liu YH; Li JH; Wang ZK; Liu JX; Yuan ZH
World J Gastroenterol; 2012 Jun; 18(22):2850-8. PubMed ID: 22719196
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro.
Thompson AJ; Colledge D; Rodgers S; Wilson R; Revill P; Desmond P; Mansell A; Visvanathan K; Locarnini S
Antivir Ther; 2009; 14(6):797-808. PubMed ID: 19812442
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-35 Level Is Elevated in Patients with Chronic Hepatitis B Virus Infection.
Cheng ST; Yuan D; Liu Y; Huang Y; Chen X; Yu HB; He L; Jiang H; Ren JH; Chen J
Int J Med Sci; 2018; 15(2):188-194. PubMed ID: 29333103
[No Abstract] [Full Text] [Related]
15. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M
J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154
[TBL] [Abstract][Full Text] [Related]
16. Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.
Chen J; Xu W; Chen Y; Xie X; Zhang Y; Ma C; Yang Q; Han Y; Zhu C; Xiong Y; Wu K; Liu F; Liu Y; Wu J
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122987
[TBL] [Abstract][Full Text] [Related]
17. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
Hagelstein J; Kist A; Stremmel W; Galle PR
Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-35 stimulates hepatitis B virus transcription and replication by targeting transcription factor HNF4α.
Tao NN; Gong R; Chen X; He L; Ren F; Yu HB; Chen J; Ren JH
J Gen Virol; 2018 May; 99(5):645-654. PubMed ID: 29561254
[TBL] [Abstract][Full Text] [Related]
19. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
[TBL] [Abstract][Full Text] [Related]
20. IL-33 Enhances Humoral Immunity Against Chronic HBV Infection Through Activating CD4(+)CXCR5(+) TFH Cells.
Zhao PW; Shi X; Li C; Ayana DA; Niu JQ; Feng JY; Wang J; Jiang YF
J Interferon Cytokine Res; 2015 Jun; 35(6):454-63. PubMed ID: 25714983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]